Active Filter(s):
Details:
Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections and zero fingersticks.
Lead Product(s): Insulin
Therapeutic Area: Endocrinology Product Name: Omnipod
Highest Development Status: Approved Product Type: Peptide
Partner/Sponsor/Collaborator: Insulet Corporation
Deal Size: $25.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition February 13, 2023